Lista de obras -

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

artículo científico publicado en 2020

Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial

artículo científico publicado en 2019

Attracting, equipping and retaining young medical doctors in HIV vaccine science in South Africa

artículo científico publicado en 2015

Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials

artículo científico publicado en 2017

Beyond Blood Smears: Qualification of Plasmodium 18S rRNA as a Biomarker for Controlled Human Malaria Infections.

artículo científico publicado en 2019

Complete attenuation of genetically engineered Plasmodium falciparum sporozoites in human subjects

artículo científico publicado en 2017

Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.

artículo científico publicado en 2015

Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization

artículo científico publicado en 2017

Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents

artículo científico publicado en 2005

Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa

artículo científico publicado en 2006

Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study

artículo científico publicado en 2005

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

artículo científico publicado en 2015

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine

artículo científico publicado en 2013

Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization

artículo científico publicado en 2016

Generation and evaluation of clade C simian-human immunodeficiency virus challenge stocks

artículo científico publicado en 2014

HIV Vaccine Trials Network: activities and achievements of the first decade and beyond

artículo científico publicado en 2012

HIV-1 vaccines and adaptive trial designs

artículo científico publicado en 2011

Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?

artículo científico publicado en 2013

Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?

artículo científico publicado en 2013

Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine

artículo científico publicado en 2011

Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa

scientific article published on 01 September 2019

In pursuit of an HIV vaccine: designing efficacy trials in the context of partially effective nonvaccine prevention modalities

scientific article published on 25 June 2013

Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02

artículo científico publicado en 2016

Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials

artículo científico publicado en 2015

PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection

artículo científico

Post-step modifications for research on HIV vaccines

artículo científico publicado en 2009

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses

artículo científico publicado en 2014

Pregnancy incidence and correlates during the HVTN 503 Phambili HIV vaccine trial conducted among South African women

artículo científico publicado en 2012

Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial ⬇️

artículo científico publicado el 31 de marzo de 2011

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

artículo científico publicado en 2014

Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults

article

Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults

artículo científico publicado en 2010

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

artículo científico publicado en 2011

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

artículo científico publicado en 2020

Selection of HIV vaccine candidates for concurrent testing in an efficacy trial

artículo científico publicado en 2016

Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants

artículo científico publicado en 2016

Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.

artículo científico publicado en 2017

Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.

artículo científico publicado en 2018

Understanding HIV epidemics: aggregate viral load metrics and 'smoking guns'.

artículo científico publicado en 2013

Uptake of male circumcision in an HIV vaccine efficacy trial

artículo científico publicado en 2009

Use of placebos in Phase 1 preventive HIV vaccine clinical trials

artículo científico publicado en 2014

Vaginal practices among women at risk for HIV acquisition in Soweto, South Africa

scientific article published on 20 June 2019

Lista de obras de

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial

Attracting, equipping and retaining young medical doctors in HIV vaccine science in South Africa

Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials

Beyond Blood Smears: Qualification of Plasmodium 18S rRNA as a Biomarker for Controlled Human Malaria Infections.

Complete attenuation of genetically engineered Plasmodium falciparum sporozoites in human subjects

Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.

Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization

Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents

Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa

Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine

Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization

Generation and evaluation of clade C simian-human immunodeficiency virus challenge stocks

HIV Vaccine Trials Network: activities and achievements of the first decade and beyond

HIV-1 vaccines and adaptive trial designs

Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?

Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?

Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine

Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa

In pursuit of an HIV vaccine: designing efficacy trials in the context of partially effective nonvaccine prevention modalities

Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02

Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials

PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection

Post-step modifications for research on HIV vaccines

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses

Pregnancy incidence and correlates during the HVTN 503 Phambili HIV vaccine trial conducted among South African women

Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial ⬇️

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults

Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

Selection of HIV vaccine candidates for concurrent testing in an efficacy trial

Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants

Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.

Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.

Understanding HIV epidemics: aggregate viral load metrics and 'smoking guns'.

Uptake of male circumcision in an HIV vaccine efficacy trial

Use of placebos in Phase 1 preventive HIV vaccine clinical trials

Vaginal practices among women at risk for HIV acquisition in Soweto, South Africa